This article is more than 5 years old. Information may no longer be current.
VIDEO: Talley discusses David Sun lecture on advances in functional GI disorders
Click Here to Manage Email Alerts
LAS VEGAS — In this exclusive video, Nicholas J. Talley, MD, PhD, professor of medicine and pro vice-chancellor of global research at the University of Newcastle, Australia, discusses the David Sun Lecture, which he delivered at ACG 2016. This distinguished lecture focused on new developments in functional gut disorders.
“First of all, there are some functional gut disorders that are potentially curable,” including rumination, cannabinoid hyperemesis syndrome, opioid bowel dysfunction and pelvic floor dyssynergia, he said.
“I also discussed new concepts in functional dyspepsia,” including the recognition that these patients often have inflammation, which “may lead to new treatment paradigms for this common condition,” he said.
Finally, he noted there are “real advances occurring” in understanding the causes of IBS, including a genetic abnormality in the sodium channel gene, the relevance of chronic infections, and post-infectious IBS, all of which may lead to new treatments in the future.
Reference:
Talley NJ. David Sun Lecture. Presented at: American College of Gastroenterology Annual Scientific Meeting; Oct. 17-19, 2016; Las Vegas, NV.
Disclosures: Talley reports he serves on the advisory committees or boards of Australian Medical Council, MBS Review Taskforce, NHMRC CI, Sax Institute and The Committee of Presidents of the Medical Colleges, is a consultant for Adelphi Values, Allergan, GI Therapies and Yuhan, has received grant/research support from Abbott Pharmaceuticals, Janssen, NHMRC CI, Pfizer, Prometheus, Rome Foundation and Salix, is the Editor in Chief of the Medical Journal of Australia, and holds patents for biomarkers of irritable bowel syndrome, EoE pathway, licensing questionnaires and nanotechnology.